Nightingale applies for its shares to be listed on the Main Market of Nasdaq Helsinki
By Antti Luiro
Translation: Original published in Finnish on 03/12/2025 at 06:34 pm EET
The submission of the application for moving to the main list was expected, as the company announced in November that it was looking into it. Trading in Nightingale's B shares is expected to commence on the Main Market of Nasdaq Helsinki on Wednesday next week, March 19, and at the same time the shares will be removed from the First North Growth Market Finland marketplace. Nightingale is also still investigating the OTC trading of its shares in the US, and we consider it quite likely that after the main list transfer, the company will apply for an OTC listing later in the spring.
The changes are driven by the internationalization of the company’s business. Nightingale has entered into a wide range of international partnerships, many of which have been in the US, so we do not think it is far-fetched to expect investor interest in the US market. In principle, a transfer to the main list and trading on the OTC market would facilitate international investments in the company.
The news has no impact on our view of the stock and we commented more extensively on this earlier in November here.
Login required
This content is only available for logged in users
Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.
Read more on company pageKey Estimate Figures07.03.
| 2024 | 25e | 26e | |
|---|---|---|---|
| Revenue | 4.4 | 5.2 | 8.2 |
| growth-% | 4.2 % | 19.2 % | 58.2 % |
| EBIT (adj.) | -18.6 | -17.3 | -16.2 |
| EBIT-% (adj.) | -426.6 % | -332.6 % | -197.1 % |
| EPS (adj.) | -0.29 | -0.27 | -0.25 |
| Dividend | 0.00 | 0.00 | 0.00 |
| Dividend % | |||
| P/E (adj.) | neg. | neg. | neg. |
| EV/EBITDA | neg. | neg. | neg. |
Forum discussions
